Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

References for PMC Articles for PubMed (Select 20724677)

1.

Cigarette smoking among adults and trends in smoking cessation - United States, 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1227-32.

2.

Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.

Mills EJ, Wu P, Spurden D, Ebbert JO, Wilson K.

Harm Reduct J. 2009 Sep 18;6:25. doi: 10.1186/1477-7517-6-25.

3.

Motivation and patch treatment for HIV+ smokers: a randomized controlled trial.

Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, Flanigan T, Morrow K, Neighbors C, Niaura R.

Addiction. 2009 Nov;104(11):1891-900. doi: 10.1111/j.1360-0443.2009.02623.x. Epub 2009 Aug 28.

4.

Update on cardiovascular complications in HIV infection.

Currier JS.

Top HIV Med. 2009 Jul-Aug;17(3):98-103. Review.

5.

Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans.

Crothers K, Goulet JL, Rodriguez-Barradas MC, Gibert CL, Oursler KA, Goetz MB, Crystal S, Leaf DA, Butt AA, Braithwaite RS, Peck R, Justice AC.

AIDS Educ Prev. 2009 Jun;21(3 Suppl):40-53. doi: 10.1521/aeap.2009.21.3_supp.40.

6.

Review: the need for smoking cessation among HIV-positive smokers.

Nahvi S, Cooperman NA.

AIDS Educ Prev. 2009 Jun;21(3 Suppl):14-27. doi: 10.1521/aeap.2009.21.3_supp.14. Review.

7.

Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil.

Pacheco AG, Tuboi SH, May SB, Moreira LF, Ramadas L, Nunes EP, Merçon M, Faulhaber JC, Harrison LH, Schechter M.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):624-30. doi: 10.1097/QAI.0b013e3181a4ecf5.

8.

Cardiovascular complications in HIV management: past, present, and future.

Aberg JA.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):54-64. doi: 10.1097/QAI.0b013e31818ceaa4. Review. Erratum in: J Acquir Immune Defic Syndr. 2009 May 1;51(1):110.

9.

Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey.

Bonnet F, Burty C, Lewden C, Costagliola D, May T, Bouteloup V, Rosenthal E, Jougla E, Cacoub P, Salmon D, Chêne G, Morlat P; Agence Nationale de Recherches sur le Sida et les Hépatites Virales EN19 Mortalité Study Group; Mortavic Study Group.

Clin Infect Dis. 2009 Mar 1;48(5):633-9.

10.

Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1226-8.

11.

The role of HIV in serious diseases other than AIDS.

Phillips AN, Neaton J, Lundgren JD.

AIDS. 2008 Nov 30;22(18):2409-18. doi: 10.1097/QAD.0b013e3283174636. Review. No abstract available.

12.

Efavirenz induces CYP2B6-mediated hydroxylation of bupropion in healthy subjects.

Robertson SM, Maldarelli F, Natarajan V, Formentini E, Alfaro RM, Penzak SR.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):513-9. doi: 10.1097/QAI.0b013e318183a425.

PMID:
18989234
13.

Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation.

Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE.

AIDS Behav. 2010 Aug;14(4):824-35. doi: 10.1007/s10461-008-9449-2.

PMID:
18777131
14.

Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption.

Gordin FM, Roediger MP, Girard PM, Lundgren JD, Miro JM, Palfreeman A, Rodriguez-Barradas MC, Wolff MJ, Easterbrook PJ, Clezy K, Slater LN.

Am J Respir Crit Care Med. 2008 Sep 15;178(6):630-6. doi: 10.1164/rccm.200804-617OC. Epub 2008 Jul 10.

15.

A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.

Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff.

Am J Prev Med. 2008 Aug;35(2):158-76. doi: 10.1016/j.amepre.2008.04.009. Review.

16.

Determination of the underlying cause of death in three multicenter international HIV clinical trials.

Lifson AR; INSIGHT Cause of Death Writing Group, Belloso WH, Carey C, Davey RT, Duprez D, El-Sadr WM, Gatell JM, Gey DC, Hoy JF, Krum EA, Nelson R, Nixon DE, Paton N, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson J, Worley J.

HIV Clin Trials. 2008 May-Jun;9(3):177-85. doi: 10.1310/hct0903-177.

17.

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.

Strategies for Management of Antiretroviral Therapy (SMART) Study Group, Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, Girard PM, Grund B, Law M, Losso MH, Palfreeman A, Wood R.

J Infect Dis. 2008 Apr 15;197(8):1133-44. doi: 10.1086/586713.

18.

Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.

Madeddu G, Porqueddu EM, Cambosu F, Saba F, Fois AG, Pirina P, Mura MS.

Infection. 2008 Jun;36(3):231-6. doi: 10.1007/s15010-007-7162-0. Epub 2008 May 10.

PMID:
18463787
19.

A test of motivational plus nicotine replacement interventions for HIV positive smokers.

Ingersoll KS, Cropsey KL, Heckman CJ.

AIDS Behav. 2009 Jun;13(3):545-54. Epub 2007 Dec 8.

20.

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.

Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, Cooper DA, Emery S; INITIO Trial International Coordinating Committee.

AIDS. 2007 Nov 30;21(18):2445-53.

PMID:
18025881
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk